Novocure Newsroom

NovoCure Analyst Ratings

BenzingaNov 21 13:01 ET

NovoCure's Buy Rating Backed by FDA Approval and Strategic Growth Plans Amidst Potential Risks

TipRanksNov 21 10:34 ET

H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsNov 21 10:32 ET

Analysts Conflicted on These Healthcare Names: Penumbra (PEN), Kymera Therapeutics (KYMR) and NovoCure (NVCR)

TipRanksNov 5 07:42 ET

NovoCure Analyst Ratings

BenzingaOct 31 05:35 ET

H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsOct 30 11:31 ET

Piper Sandler Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $28

Moomoo NewsOct 25 08:35 ET

Piper Sandler Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $28

Moomoo NewsOct 17 06:36 ET

Leerink Partners Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $28

Moomoo NewsOct 16 15:31 ET

A Quick Look at Today's Ratings for Novocure(NVCR.US), With a Forecast Between $28 to $40

Moomoo NewsOct 16 09:04 ET

Piper Sandler Reaffirms Their Buy Rating on NovoCure (NVCR)

TipRanksOct 16 08:10 ET

NovoCure Analyst Ratings

BenzingaOct 16 06:13 ET

Novocure Upgraded to Buy From Neutral at H.C. Wainwright

TipRanksOct 16 06:12 ET

Buy Rating Affirmed for NovoCure as FDA Approval Expands Optune's Market Potential

TipRanksOct 15 20:00 ET

Novocure Is Maintained at In-Line by Evercore ISI Group

Dow JonesOct 1 13:05 ET

NovoCure Analyst Ratings

BenzingaOct 1 12:55 ET

Evercore Maintains Novocure(NVCR.US) With Hold Rating, Cuts Target Price to $18

Moomoo NewsOct 1 09:31 ET

Wells Fargo Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsSep 4 05:32 ET

Wells Fargo Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $40

Moomoo NewsJul 26 07:31 ET

Wells Fargo Remains a Buy on NovoCure (NVCR)

TipRanksJul 26 07:24 ET